Session IX - Upper Extremity


Moderator: David S. Ruch, MD & Margaret M. McQueen, MD


Sat., 10/20/07 Upper Extremity, Paper #53, 10:30 am OTA-2007

Comparison of Superior and Anteroinferior Plate Placement in the Treatment of Clavicle Fractures

Robert S. Rice, MD* (n); S. Andrew Sems, MD1 (n); Michael E. Torchia, MD1 (n);
Peter A. Cole, MD2 (a-Biomet/EBI, DePuy, Smith+Nephew, Synthes, Zimmer);
Adam Bloemke, MD2 (n); Andrew H. Schmidt, MD3 (e-Smith+Nephew);
1Mayo Clinic, Rochester, Minnesota, USA;
2University of Minnesota-Regions Hospital, St. Paul, Minnesota, USA;
3Hennepin County Medical Center, Minneapolis, Minnesota, USA


Sat., 10/20/07 Upper Extremity, Paper #54, 10:36 am OTA-2007

Glenoid Fractures Do Not Medialize

William T. Obremskey, MD, MPH1 (a-Synthes); Bryan Armitage, BA2 (n); Bradley Corr, BA1 (n);
1Vanderbilt University, Nashville, Tennessee, USA;
2University of Minnesota, Minneapolis, Minnesota, USA


Sat., 10/20/07 Upper Extremity, Paper #55, 10:42 am OTA-2007

CT Evaluation of Extra-Articular Glenoid Neck Fractures: Does the Glenoid Medialize or Does the Scapula Lateralize?

J. Megan M. Patterson, MD1 (n); Leesa Galatz, MD1 (n); Jared Toman, MD2 (n);
Paul Tornetta, III, MD2 (a,c,e-Smith+Nephew),
William M. Ricci, MD1 (a,c,e-Smith+Nephew; a-Synthes, AONA);
1Washington University School of Medicine, St. Louis, Missouri, USA;
2Boston Medical Center, Boston, Massachusetts, USA


Sat., 10/20/07 Upper Extremity, Paper #56, 10:55 am OTA-2007

Correspondence between Objective Physical Impairment and Patient-Rated Disability after Elbow Trauma

Anneluuk Lindenhovius, MSc1 (a-Annafonds, Stichting Professor Michael van Vloten Fonds, Stichting Wetenschappelijk Onderzoek Orthopaedie, AO Foundation, Small Bone Innovations, Smith+Nephew Richards, Wright Medical, Joint Active Systems, Biomet); Geert Buijze, MSc2; Peter Kloen, MD, PhD2 (n); David Ring, MD, PhD1 (a-AO Foundation, Small Bone Innovations, Joint Active Systems, Biomet; c-Hand Innovations; a,e-Smith+Nephew Richards, Wright Medical);
1Orthopaedic Hand Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA;
2Department of Orthopaedic Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands


Sat., 10/20/07 Upper Extremity, Paper #57, 11:01 am OTA-2007

Distal Humerus Fractures (OTA 13C) in the Osteoporotic Elbow: Plate Fixation versus Total Elbow Arthroplasty

Kenneth A. Egol, MD (a-Synthes, Stryker, Biomet, Smith+Nephew);
Peter Tsai, MD (n); Nirmal C. Tejwani, MD (e-Zimmer, Biomet);
NYU Hospital for Joint Diseases, New York, New York, USA


Sat., 10/20/07 Upper Extremity, Paper #58, 11:13 am OTA-2007

Determinants of Health Status and Wrist Function after Operative Fixation of Distal Radius Fractures

J. Sebastiaan Souer, MD (a-AO Foundation, Small Bone Innovations, Smith+Nephew Richards, Wright Medical, Joint Active Systems, Biomet, Prof. Michael van Vloten Fonds);
Lozano-Calderon Santiago, MD (a-AO Foundation, Small Bone Innovations, Smith+Nephew Richards, Wright Medical, Joint Active Systems, Biomet, Prof. Michael van Vloten Fonds);
Jesse Jupiter, MD (a-AO Foundation, Small Bone Innovations, Smith+Nephew Richards,
Wright Medical, Joint Active Systems; e-Wyeth Co., Amgen Co.);
David Ring, MD, PhD (a-AO Foundation, Small Bone Innovations, Joint Active Systems, Biomet; c-Hand Innovations; a,e-Smith+Nephew Richards, Wright Medical);
Massachusetts General Hospital, Boston, Massachusetts, USA


Sat., 10/20/07 Upper Extremity, Paper #59, 11:19 am OTA-2007

Patient Outcome Five Years following Colles’ Fracture

Jessica E. Farmer, MD (n); Abizar Aladin, MD (n); Steve A. Earnshaw, MD (n);
Chris Boulton (n); Chris G. Moran, MD (n);
Queen’s Medical Centre, Nottingham, United Kingdom


If noted, the author indicates something of value received. The codes are identified as a-research or institutional support; b-miscellaneous funding; c-royalties; d-stock options; e-consultant or employee; n-no conflicts disclosed, and *disclosure not available at time of printing.

• The FDA has not cleared this drug and/or medical device for the use described in this presentation   (i.e., the drug or medical device is being discussed for an “off label” use).  ◆FDA information not available at time of printing.